Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
CAAR-Ts represent a targeted approach to therapy of antibody-mediated autoimmune diseases, with the potential for generation of long-term memory CAAR-Ts that can potentially cure disease. Autoantigen-based chimeric immunoreceptors (CAAR) can direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR). The vector of anti-U1-RNP chimeric autoantigen receptor (CAAR) is constructed for the engineering of T cells to target Human U1-RNP. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-U1-RNP antibody linked to Mixed connective tissue
disease.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.